When combining ER, PR and HER2 as variables of breast cancer subtype, ERBB2+ and basal-like subtypes, both contributed to the risk of LN involvement (OR 1.773, 95% CI 1.543–2.037). Here, ERBB2 is linked to breast carcinoma.